RE: A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer14 Mar 2022 19:28
Sra737 was aways effective, LTHs knew it was naive of the board to license srra the way they did. We hope it would be returned so it could be progressed via other means. Don’t forget CRUK have a stake in this, all trials proved positive. Srra had other ideas and we are stuck with them for the duration of the license.